contracting office, code 75A501, Washington, DC
Barda - Aspr / Daappo / Barda DCMA
72 opportunities published since January 1, 2024, 3 open now. 754 awards on USAspending in the same window, $6,641,592,044 obligated, 81% of them under full and open competition.
Hear about each solicitation Barda - Aspr / Daappo / Barda DCMA posts, the day it is posted.Follow it
Closing soonest
3 solicitations are accepting responses.
- Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture DetectionSources soughtNAICS 334510Anywhere in the USBARDA-FY27-10192026Closes in 17 daysNov 18
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & ResponseSolicitationNAICS 541714Washington, DC75A50126R00001_RFP_NPIVS_27Closes in 19 daysNov 20
- BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)SolicitationNAICS 541714Anywhere in the USDRIVeEZBAA22100SOL00003Closes in 351 daysOct 18, 2027
Contracts ending soon
Awards Barda - Aspr / Daappo / Barda DCMA made whose performance ends in the next 19 months, by published end date. Each one is a recompete to prepare for.
- Ending
- 86
- Obligated so far
- $519,918,883
- Soonest
- October 30, 2026
The 86 contracts, who holds each one and the dates are in the workspace. See them
Who wins here
Vendors by dollars obligated.
| Advanced Technology International | $2,345,717,825 |
| Seqirus Inc. | $544,124,223 |
| Bavarian Nordic A/S | $463,447,837 |
| Albert B. Sabin Vaccine Institute, Inc. (The) | $356,898,734 |
| Amgen USA Inc. | $345,768,625 |
| Start2 Group, Inc. | $227,139,021 |
| Emergent Product Development Gaithersburg Inc. | $192,425,268 |
| Siga Technologies, Inc. | $167,743,809 |
| Sanofi Vaccines US Inc. | $158,679,116 |
| Shionogi Inc. | $156,103,541 |
What it buys
Industries by dollars obligated.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $4,926,851,556 |
| Pharmaceutical Preparation ManufacturingNAICS 325412 | $636,865,321 |
| Biological Product (except Diagnostic) ManufacturingNAICS 325414 | $586,752,431 |
| Industrial Building ConstructionNAICS 236210 | $423,762,396 |
| Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)NAICS 541715 | $200,516,630 |
| Administrative Management and General Management Consulting ServicesNAICS 541611 | $160,636,504 |
| Other Measuring and Controlling Device ManufacturingNAICS 334519 | $55,566,505 |
| Blood and Organ BanksNAICS 621991 | $42,750,172 |
| Surgical Appliance and Supplies ManufacturingNAICS 339113 | $25,650,285 |
| All Other Professional, Scientific, and Technical ServicesNAICS 541990 | $8,744,821 |
How it buys
Awards by competition and by set-aside.
| Full and Open Competition | 607 |
| Not Competed | 54 |
| Full and Open Competition After Exclusion of Sources | 35 |
| Not Competed Under SAP | 28 |
| Competed Under SAP | 26 |
| Small Business Set Aside - Total | 19 |
| 8(A) Sole Source | 4 |
| Small Business Set Aside - Partial | 2 |
| 8A Competed | 1 |
| Women Owned Small Business | 1 |
Recently published
- Request for Proposals (RFP) - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & ResponseSolicitationNAICS 541714Washington, DC75A50126R00001_RFP_NPIVS_27Closes in 19 daysNov 20
- Automated Ultrasound-Based, Super Intelligence (SI)-Enabled Fracture DetectionSources soughtNAICS 334510Anywhere in the USBARDA-FY27-10192026Closes in 17 daysNov 18
- J&A to extend Period or Performance for procurement of InmazebJustificationNAICS 541714Tarrytown, NYJOFOC-REG-1
Awarded to Regeneron Pharmaceuticals Inc.
Posted Oct 10 - RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)Award noticeNAICS 541714Washington, DC75A50126R00002
Awarded to Kaleo, Inc. for $340,910,795
Posted Sep 307 publications - Advanced Development of OXOS X3, a Point-of-Care Diagnostic X-Ray Imaging System for Detection of Fracture and other TraumaSpecial noticeNAICS 541714Atlanta, GA75A50126C00011
Awarded to Oxos Medical Inc.
Posted Sep 29 - Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formulaAward noticeNAICS 541714Jersey City, NJBAA-23-100-SOL-00004
Awarded to Kaleo, Inc. for $213,943,726
Posted Sep 2510 publications - Presolicitation Notice - BARDA Vaccine Medical Countermeasures for Pandemic Influenza Preparedness & ResponsePresolicitationNAICS 541714Washington, DC75A50126R00001_RFP_PreSolNotice_NPIVS-2027Posted Jul 30
- Repurposing Equipment for Drug Delivery (REDD)Sources soughtNAICS 541714Washington, DCREDDPosted Jun 29
- Bundibugyo Virus Outbreak Response Vaccines (BundiVx) - RRPV ConsortiumSolicitationNAICS 541714Washington, DCRRPV-26-13-BundiVxPosted Jun 184 publications
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)Award noticeNAICS 541714California75A50126C00006
Awarded to Flosonics Medical LLC for $99,727,959
Posted Jun 5
Recently awarded
- J&A to extend Period or Performance for procurement of InmazebJustificationNAICS 541714Tarrytown, NYJOFOC-REG-1
Awarded to Regeneron Pharmaceuticals Inc.
Posted Oct 10 - RFP - 2-PAM Autoinjectors for Project Bioshield (PBS)Award noticeNAICS 541714Washington, DC75A50126R00002
Awarded to Kaleo, Inc. for $340,910,795
Posted Sep 307 publications - Advanced Development of OXOS X3, a Point-of-Care Diagnostic X-Ray Imaging System for Detection of Fracture and other TraumaSpecial noticeNAICS 541714Atlanta, GA75A50126C00011
Awarded to Oxos Medical Inc.
Posted Sep 29 - Advance the development of SCY-247, a novel antifungal currently in Phase 1 clinical trials, for the treatment of invasive candidiasis and prophylaxis of invasive fungal disease as oral and IC formulaAward noticeNAICS 541714Jersey City, NJBAA-23-100-SOL-00004
Awarded to Kaleo, Inc. for $213,943,726
Posted Sep 2510 publications - Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)Award noticeNAICS 541714California75A50126C00006
Awarded to Flosonics Medical LLC for $99,727,959
Posted Jun 5 - Strategic Marburg Advanced Research and Development, Preparedness, Registration, Evaluation and Procurement (SMART-PREP)Award noticeNAICS 541714Anywhere in the US75A50125R00006
Awarded to Albert B. Sabin Vaccine Institute, Inc. (The) for $1,042,099,118
Posted May 75 publications - BARDA DRIVe EZ-BAA (EZBAA - 22-100-SOL-00003)Award noticeNAICS 541714Minneapolis, MN75A50126C00005
Awarded to Isola Therapeutics Inc. for $7,485,417
Posted Apr 27 - Justification and Approval for Other than Full and Open Competition _ Nonclinical Chemical Network IDIQ ProviderJustificationNAICS 541714Anywhere in the US75A50122D00007
Awarded to Battelle Memorial Institute
Posted Apr 22
Notice types
- Special notices25
- Award notices18
- Sources sought16 (1 open)
- Solicitations7 (2 open)
- Justifications4
- Presolicitations2
Set-asides
Where this agency buys
- At a site in one state52 (1 open)
- Anywhere in the US18 (2 open)
- Outside the US1
- Location not published1
Place of performance
- Product and service codes
- AN42 Health R&D Services; Health Care - Other; Applied ResearchAN13 Health R&D Services; Health Care Services; Experimental Development6505 Drugs and BiologicalsAD61 AN12 Health R&D Services; Health Care Services; Applied ResearchR408 Program Management/Support Services
- Awards seen
- January 2, 2024 to October 27, 2026
- Data as of
- November 1, 2026